EILEEN ROTHROCK: Open Payments
NPI 1659440550 · HUNTINGDON VALLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 56 payments from 18 companies in 2025. Trend: 2023 $1,456 · 2024 $1,202 · 2025 $984
Food & beverage: $969Education: $15
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $164 |
| Braeburn Inc. | 6 | $113 |
| ABBVIE INC. | 5 | $99 |
| Neurocrine BioSciences, Inc. | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Amgen Inc. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Alkermes, Inc. | 2 | $38 |
Products named: CAPLYTA, BRIXADI, INGREZZA, COBENFY, INVEGA SUSTENNA, QULIPTA, OTEZLA, FANAPT.
Industry payments across PA — which companies pay providers there.
